Resveratrol

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameResveratrol
Drug Alias Name白藜芦醇GSK-184072SRT-501RM-1812
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsSolid tumoursSchizophreniaCognitive Dysfunction +[30] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPortugal +[15] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEvolva
China Registration ClassN/A

Develop Information

Active CompaniesAugusta UniversityGeorgetown UniversityJupiter Orphan Therapeutics +[11] 
Inactive CompaniesBial - Portela C SaUniversity Of California San FranciscoUniversity of California Irvine +[18] 
Active IndicationsCognitive DysfunctionFoodborne DiseasesDyslipidemias +[14] 
Inactive IndicationsSolid tumoursSchizophreniaHealthy Aging +[16] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG